Departments of Pediatrics, Microbiology, Neurobiology, University of Alabama School of Medicine, Birmingham, Alabama.
J Infect Dis. 2020 Mar 5;221(Suppl 1):S1-S8. doi: 10.1093/infdis/jiz464.
Human cytomegalovirus (HCMV) infection remains an important cause of neurodevelopmental sequelae in infants infected in utero. Unique to the natural history of perinatal HCMV infections is the occurrence of congenital HCMV infections (cCMV) in women with existing immunity to HCMV, infections that have been designated as nonprimary maternal infection. In maternal populations with a high HCMV seroprevalence, cCMV that follows nonprimary maternal infections accounts for 75%-90% of all cases of cCMV infections as well as a large proportion of infected infants with neurodevelopmental sequelae. Although considerable effort has been directed toward understanding immune correlates that can modify maternal infections and intrauterine transmission, the source of virus leading to nonprimary maternal infections and intrauterine transmission is not well defined. Previous paradigms that included reactivation of latent virus as the source of infection in immune women have been challenged by studies demonstrating acquisition and transmission of antigenically distinct viruses, a finding suggesting that reinfection through exposure to an exogenous virus is responsible for some cases of nonprimary maternal infection. Additional understanding of the source(s) of virus that leads to nonprimary maternal infection will be of considerable value in the development and testing of interventions such as vaccines designed to limit the incidence of cCMV in populations with high HCMV seroprevalence.
人巨细胞病毒(HCMV)感染仍然是宫内感染婴儿神经发育后遗症的重要原因。围产期 HCMV 感染的独特之处在于,在对 HCMV 具有现有免疫力的女性中发生先天性 HCMV 感染(cCMV),这些感染被指定为非原发性母体感染。在 HCMV 血清阳性率较高的母体人群中,继发于非原发性母体感染的 cCMV 占所有 cCMV 感染病例的 75%-90%,以及相当大比例的感染婴儿存在神经发育后遗症。尽管人们已经做出了相当大的努力来了解可以改变母体感染和宫内传播的免疫相关性,但导致非原发性母体感染和宫内传播的病毒来源尚未明确。先前的一些模式包括潜伏病毒的激活作为免疫女性感染的来源,但研究表明,抗原性不同的病毒的获得和传播对这些模式提出了挑战,这一发现表明,通过接触外源病毒再次感染是导致某些非原发性母体感染的原因。进一步了解导致非原发性母体感染的病毒来源,对于开发和测试干预措施(如旨在降低高 HCMV 血清阳性率人群中 cCMV 发病率的疫苗)将具有重要价值。